Downgrades Buy Neutral X

STAA STAAR Surgical

BTIG Research

Downgrades Buy Hold X

STAA STAAR Surgical

Jefferies

Downgrades Outperform Neutral X

STAA STAAR Surgical

Mizuho

$45 $17

Downgrades Outperform Mkt Perform X

STAA STAAR Surgical

William Blair

Downgrades Eq-Weight Underweight X

STAA STAAR Surgical

Morgan Stanley

$50 $37

Upgrades Neutral Buy X

STAA STAAR Surgical

BTIG Research

$46

Upgrades Hold Buy X

STAA STAAR Surgical

Stifel

$30 $50

Downgrades Buy Hold X

STAA STAAR Surgical

Needham

Initiated Equal-Weight X

STAA STAAR Surgical

Morgan Stanley

$35

Downgrades Buy Hold X

STAA STAAR Surgical

The Benchmark Company

Downgrades Buy Hold X

STAA STAAR Surgical

Canaccord Genuity

$77 $48

Downgrades Outperform Mkt Perform X

STAA STAAR Surgical

William Blair

Initiated Neutral X

STAA STAAR Surgical

Piper Sandler

$65

Downgrades Buy Neutral X

STAA STAAR Surgical

BTIG Research

Initiated Hold X

STAA STAAR Surgical

Stifel

$60

Upgrades Neutral Buy X

STAA STAAR Surgical

Sidoti

Resumed Overweight X

STAA STAAR Surgical

Stephens

$91

Initiated Buy X

STAA STAAR Surgical

Mizuho

$85

Initiated Buy X

STAA STAAR Surgical

Needham

$87

Upgrades Hold Buy X

STAA STAAR Surgical

The Benchmark Company

$97

Upgrades Neutral Buy X

STAA STAAR Surgical

BTIG Research

$98

Initiated Perform X

STAA STAAR Surgical

Oppenheimer

$150

Downgrades Buy Hold X

STAA STAAR Surgical

The Benchmark Company

Reiterated Buy X

STAA STAAR Surgical

The Benchmark Company

$45 $54

Resumed Buy X

STAA STAAR Surgical

The Benchmark Company

$45

STAA  STAAR Surgical Company

STAAR Surgical Company designs, develops, manufactures and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. It operates in the ophthalmic surgical market segment. Its principal products are intraocular lenses used in cataract surgery and implantable collamer lenses used in refractive surgery. It makes lenses used across the world in corrective or refractive surgery, and makes lenses for use in surgery that treats cataracts. Its refractive surgery corrects the types of visual disorders that glasses or contact lenses have treated (myopia, hyperopia, astigmatism and presbyopia). Its refractive surgery corrects the types of visual disorders that glasses or contact lenses have treated (myopia, hyperopia, astigmatism and presbyopia). As of December 30, 2016, it sold its products in more than 60 countries, with direct distribution in the United States, Canada, Japan and Spain, and independent distribution in the remainder of the world.